Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
36,887
Sort by:
Colombia Republic Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities
US$ 3,850.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors ...
May 2019
535 pages
Czech Republic Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities
US$ 3,850.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors ...
May 2019
535 pages
Hong Kong Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities
US$ 3,850.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth Factors ...
May 2019
535 pages
